Literature DB >> 10366458

Adenocarcinoma in situ of the cervix: management and outcome.

M Azodi1, S K Chambers, T J Rutherford, E I Kohorn, P E Schwartz, J T Chambers.   

Abstract

OBJECTIVE: The aim of this study was to review the management and outcome of patients with adenocarcinoma in situ of the cervix and to evaluate the significance of endocervical cone margin status in these patients.
METHODS: A retrospective review of records between January 1988 and December 1996 identified 40 patients with adenocarcinoma in situ on cone biopsy for whom complete information was available. The median follow-up was 38 months.
RESULTS: The mean age was 37 years, and the mean parity was 1.3. Fifty-three percent of the patients had prior abnormal cervical cytology. The initial Pap smear that led to the patient's referral was abnormal in 39 (98%). Initial cervical biopsies showed adenocarcinoma in situ and/or glandular dysplasia in 28 (70%), squamous dysplasia in 2 (5%), chronic inflammation in 2 (5%), and no pathologic changes in 2 (5%) patients. Initially no biopsies were performed in 3 (7.5%) patients and the results of 3 (7.5%) biopsies were unknown. Subsequently, all patients had cone biopsies. The endocervical margins were positive for glandular abnormalities in 24% of cold knife cones (CKC), 75% of LEEPs, and 57% of laser cones. The ectocervical margins were positive for squamous and/or glandular abnormalities in 8% of CKCs, 13% of LEEPs, and 57% of laser cones. ECCs above the cone were obtained in 28 patients, and only 1 (3%) was positive. The definitive treatment was hysterectomy in 27, repeat cone in 5, and no additional therapy in 8 patients. The pathology showed residual disease in 44% of treated patients. From 16 cone biopsies with negative margins who had subsequent treatment, there was residual disease in 5 (31%) specimens (1 adenocarcinoma in situ, 1 mild glandular dysplasia, 3 glandular atypia). From 16 cones with positive margins who had subsequent treatment, there was residual disease in 9 (56%) specimens. The patients with negative ECCs above the cone regardless of margin status had residual disease in 58% of treated specimens.
CONCLUSION: Women with adenocarcinoma in situ of the uterine cervix had residual disease in 31% of cases with negative margins in cone biopsies and/or with negative ECCs and in 56% of cases with positive endocervical margins. LEEP cones had higher rate of positive endocervical margins (75%) compared to CKC (24%) and laser cone (57%). If maintaining reproductive capacity is desired, we would recommend CKC; however, this does not guarantee absence of the disease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10366458     DOI: 10.1006/gyno.1999.5395

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Atypical Papanicolaou smear in pregnancy.

Authors:  Thomas P Connolly; A C Evans
Journal:  Clin Med Res       Date:  2005-02

Review 2.  Adenocarcinoma of the cervix.

Authors:  John O Schorge; Lynne M Knowles; Jayanthi S Lea
Journal:  Curr Treat Options Oncol       Date:  2004-04

Review 3.  Fertility-Sparing Options in Young Women with Cervical Cancer.

Authors:  Federica Tomao; Giacomo Corrado; Fedro Alessandro Peccatori; Sara Boveri; Eleonora Petra Preti; Nicoletta Colombo; Fabio Landoni
Journal:  Curr Treat Options Oncol       Date:  2016-01

4.  Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma.

Authors:  Johji Imura; Yoshiaki Uchida; Kazuhiro Nomoto; Kazuhito Ichikawa; Shigeki Tomita; Tatsuo Iijima; Takahiro Fujimori
Journal:  Diagn Pathol       Date:  2012-08-17       Impact factor: 2.644

Review 5.  Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.

Authors:  Yanming Jiang; Changxian Chen; Li Li
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

6.  Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.

Authors:  Paul A Cohen; Alison Brand; Peter Sykes; David C H Wrede; Orla McNally; Lois Eva; Archana Rao; Michael Campion; Martin Stockler; Aime Powell; Jim Codde; Max K Bulsara; Lyndal Anderson; Yee Leung; Louise Farrell; Pennie Stoyles
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692

7.  Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.

Authors:  Huimin Bai; Jun Liu; Qiuxi Wang; Ying Feng; Tong Lou; Shuzhen Wang; Yue Wang; Mulan Jin; Zhenyu Zhang
Journal:  BMC Cancer       Date:  2018-04-24       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.